05:54 PM EDT, 10/08/2024 (MT Newswires) -- Joseph Michael Fitzgerald, Executive Vice President and Group President, Cardiology, on October 07, 2024, sold 132,527 shares in Boston Scientific ( BSX ) for $11,264,888. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 165,361 shares of the company, with 160,467 shares held directly and 4,894 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520824009233/xslF345X05/doc4.xml

Price: 86.01, Change: +0.17, Percent Change: +0.20